|
Originator brand medicines surveyed Syria, December 2003 |
|
||||
| Medicine name | Strength | Dosage form | Originator brand name | Originator brand manufacturer | International reference price source MSH2002 (US $) | ||
| Aciclovir | 200 mg | cap/tab | 0.0854 | ||||
| Amitriptyline | 25 mg | cap/tab | 0.0070 | ||||
| Amoxicillin | 250 mg | cap/tab | innovator not surveyed | 0.0178 | |||
| Atenolol | 50 mg | cap/tab | 0.0082 | ||||
| Beclometasone | 50 mcg/dose | inhaler | innovator not surveyed | 0.0163 | |||
| Captopril | 25 mg | cap/tab | 0.0264 | ||||
| Carbamazepine | 200 mg | cap/tab | 0.0193 | ||||
| Ceftriaxone | 1 g/vial | injection | innovator not surveyed | 3.2468 | |||
| Ciprofloxacin | 500 mg | cap/tab | innovator not surveyed | 0.0357 | |||
| Co-trimoxazole | 40+200 mg/5ml | suspension | 0.0042 | ||||
| Diazepam | 5 mg | cap/tab | 0.0029 | ||||
| Diclofenac | 25 mg | cap/tab | 0.0043 | ||||
| Diltiazem | 60 mg | cap/tab | innovator not surveyed | 0.0162 | |||
| Fluconazole | 200 mg | cap/tab | innovator not surveyed | 0.1650 | |||
| Fluoxetine | 20 mg | cap/tab | innovator not surveyed | 0.0276 | |||
| Furosemide | 40 mg | cap/tab | innovator not surveyed | 0.0046 | |||
| Glibenclamide | 5 mg | cap/tab | innovator not surveyed | 0.0049 | |||
| Loratadine | 10 mg | cap/tab | 0.0726 | ||||
| Losartan | 50 mg | cap/tab | innovator not surveyed | 1.0032 | |||
| Lovastatin | 20 mg | cap/tab | 0.1439 | ||||
| Metformin | 500 mg | cap/tab | innovator not surveyed | 0.0171 | |||
| Metronidazole | 500 mg | cap/tab | 0.0100 | ||||
| Omeprazole | 20 mg | cap/tab | innovator not surveyed | 0.1846 | |||
| Paracetamol | 500 mg | cap/tab | 0.0030 | ||||
| Phenytoin | 100 mg | cap/tab | innovator not surveyed | 0.0070 | |||
| Ranitidine | 150 mg | cap/tab | 0.0716 | ||||
| Salbutamol | 100 mcg/dose | inhaler | innovator not surveyed | 0.0085 | |||